Tuberculosis Remains a Global Public Health Burden Despite HIV/AIDS Advances

Strategic Insights -

Tuberculosis remains a major public health concern worldwide, particularly in regions with high HIV/AIDS prevalence. According to a recent study, 500,000 people died from TB in 2021, with individuals living with HIV having an 18 times higher risk of developing TB. This association with poor treatment outcomes underscores the need for integrated TB/HIV services.

Key Takeaways:

  • The study focused on individuals coinfected with HIV and TB in the Teso region, Northeastern Uganda, and examined the treatment success rate and associated factors.
  • The research analyzed data from 22 accredited diagnostic and TB unit health facilities, collecting information on patients' treatment outcomes from January 2020 to December 2021.
  • The study found that the treatment success rate was lower among patients coinfected with HIV and TB compared to those with TB alone.
  • The analysis identified several factors associated with poorer treatment outcomes, including poor adherence to treatment, delayed diagnosis, and inadequate follow-up care.
  • The study concluded that scaling up integrated TB/HIV services, ensuring viral load suppression, and increasing TB awareness are crucial steps towards achieving the end TB strategy by 2030.
  • The research highlighted the need for targeted intervention and prevention strategies to reduce the burden of TB among individuals living with HIV.
  • The study demonstrated the importance of addressing the intersection of TB and HIV to improve health outcomes and reduce mortality.

Statistics:

  • 500,000 people died from TB in 2021.
  • Individuals living with HIV have an 18 times higher risk of developing TB.
  • The treatment success rate was 62% among patients with TB alone, compared to 45% among those coinfected with HIV and TB.
  • The study analyzed data from 22 health facilities, collecting information on 1,002 patients with TB and HIV co-infection.
  • 70.5% of patients had a history of previous TB treatment.
  • The most common reason for treatment failure was poor adherence to medication (54.1%).

Sources:

  • The treatment success rate and associated factors among pulmonary bacteriologically confirmed and pulmonary clinically diagnosed drug susceptible TB coinfected with HIV in Teso Sub-Region, North-Eastern Uganda 2020-2021. a retrospective study. BMC Infectious Diseases, 2025;25(1):1249.
  • AIDS Weekly. NewsRx. October 20, 2025; p 118.